A 63-year-old man with no psychiatric history was admitted to the hospital with bilateral pneumonia and positive PCR test for COVID-19 (30 March 2020) and was diagnosed with COVID-19.
She also had delirium during hospitalization, which improved in parallel with respiratory disorder, leading to discharge of the patient (8 April 2020).
Outpatient treatment with risperidone 2mg daily was maintained, but extravagant delirium and speech and inconsistent thinking did not remit, even after a new adjustment of the antisicotic treatment April 20).
In this second admission, a new PCR test of COVID-19 was performed, with positive results.
Respiratory examination was normal.
An increase in anticoagulant D levels was detected in blood tests; a CT angiography showed a low risk of pulmonary thromboembolism, which was considered associated with IDCOV-19 and was treated with anticoagulants.
In the first psychiatric evaluation, the patient reported ideas of changes in his body, such as absence of anus, reason why he decided not to eat anything and thus avoid exploitation.
At first, attention and guidance was observed regarding time and fluctuating space, but without other usual features of delirium.
Contrast-enhanced cranial MRI did not reveal relevant results.
Finally, a diagnosis of psychotic disorder caused by another pathological process (COVID-19) was made according to DSM-5 criteria.
During the follow-up of the case by psychiatry, the content of the deliriums changed (the patient explained that most of his relatives had died) and the auditory and verbal department appeared dead.
The dose of risperidone was adjusted for the following days, from 2.5 mg per day to 6 mg per day.
On April 30, 2020, the patient had recovered almost entirely, without delirium or outpatient follow-up, and was conscious of previous psychotic symptoms, so he was discharged from psychiatric ward and referred to outpatient clinic.
